About This Webinar
Tuesday 17 November at 12:00 GMT | 07:00 ET | 20:00 SGT
Virtual event | 75-minute masterclass | Free to attend

About This Webinar

Advancing Wound Care: Evidence-Based Use of Silver from Biofilm to Healing
Explore the evidence. Address biofilm. Support wound progression.

A global virtual masterclass for healthcare professionals working in wound care.

Hard-to-heal wounds present complex clinical challenges that extend beyond bacterial burden alone. Selecting an appropriate antimicrobial dressing requires an understanding of the available evidence, the wound environment and the wider factors that may affect wound progression.

This 75-minute virtual masterclass brings scientific evidence and clinical practice together. An expert faculty will examine the evidence supporting the appropriate use of silver dressings, clarify the differences between antibiotics and silver, and explore the role of antimicrobial stewardship in everyday wound care.

The programme will consider the impact of biofilm, slough, excess exudate and wound-bed preparation on hard-to-heal wounds. Clinical evidence, including randomised controlled trial findings, and practical examples will demonstrate how silver dressings can support the management of hard-to-heal wounds, how they can be incorporated within a wound hygiene strategy, and how regular reassessment can guide decisions to continue, change or step down treatment.

By attending, participants will learn how to:

* Differentiate between antibiotic resistance, antimicrobial stewardship and appropriate antimicrobial use.
* Evaluate the evidence supporting the appropriate use of silver dressings in wound care.
* Describe why hard-to-heal wounds often require more than bacterial management alone.
* Assess the role of clinical evidence, including RCT findings, when selecting antimicrobial dressings.
* Apply a practical framework for wound hygiene, appropriate silver use, reassessment and step-down decisions.

Expert faculty
Prof Martin Storck
Clinical framing and practical application
Dan Metcalf
Silver evidence, resistance and biofilm
Rebecca Rodger
Clinical evidence and wound progression
Call to action
Register for free
Scan the QR code to reserve your place.

Join healthcare professionals from around the world for an evidence-led discussion designed to support confident, appropriate and patient-focused wound-care decisions.

Tuesday 17 November at 12:00 GMT | 07:00 ET | 20:00 SGT
Virtual event | 75-minute masterclass | Free to attend

Register now to participate in the live expert discussion and audience Q&A.

Kindly supported by Convatec
Agenda
  • Advanced Modalities
  • Principles of Wound Care Management
  • Optimisation of Outcomes
  • Interactive Patient Clinics
  • Silver Technology
  • This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®). Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC® CE credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.
  • https://services.ebac-cme.org/app/EBACMgmt/wa/poll?s=qazo
Presenters
  • 1682538964-f2413c4cef2a35fe
    Dr Negin Shamsian
    Locum Consultant Plastic and Reconstructive Surgeon and Editor Wound Masterclass
    With over 25 years of clinical experience, Dr Shamsian heads the team at Clarus Communications with Wound Masterclass being the only globally accredited, fully sustainable platform.
    She works clinically as a locum Consultant Plastic and Reconstructive Surgeon.
  • 1791667968-677a499c9a2b2859
    Dr Daniel Metcalfe
    Director, Medical Science Liaison
    Daniel Metcalf is a biochemist with a PhD in microbiology, specialising in biofilm therapy. With 22 years of experience in the wound care industry, including 20 years at Convatec, Daniel has supported the development of wound management and infection prevention technologies such as Aquacel® Ag, Aquacel® Ag+ Extra, FlexiSeal®, InnovaMatrix®, and ConvaNiox™. Daniel holds a number of patents, has received several international awards, and has published 30 papers on wound biofilm and wound care technologies. He was recently appointed as Convatec’s first Medical Science Liaison Director, following his previous role as Research & Development Director within Convatec’s Advanced Wound Care business.
  • 1792102412-3696dcb392cba66e
    Prof Martin Storck
    Vascular and Thoracic Surgeon, Professor
    Professor Martin Storck is a vascular and thoracic surgeon with extensive expertise in wound care and the management of chronic wounds. He is Director of the Department of Vascular Surgery at Klinikum Karlsruhe and Professor at the University of Freiburg. His current research includes wound-care quality assurance, AI-supported digital wound assessment and wound therapy using cold plasma technology. Professor Storck is President of the German Wound Council, was a member of the German Society for Vascular Surgery Wounds committee for many years, and a delegate to the German national S3 Guideline for Chronic Wounds. Throughout his career, he has received several research and clinical awards, including recognition for his contribution to wound-care quality improvement.
  • 1791887043-756d6262d38eb8a6
    Ms Rebecca Rodger RMCPod, BSc (Hons) Podiatry (HCPC Reg)
    Global Medical Affairs Manager /Podiatrist
    Rebecca Rodger, RMCPod, BSc (Hons) Podiatry (HCPC Reg), is a Medical Affairs Manager and a practising podiatrist. With a background spanning clinical practice, wound care research and Medical Affairs, Rebecca is passionate about translating robust clinical evidence into practical decision-making that improves wound care.
Powered by BigMarker